SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-18-000187
Filing Date
2018-06-11
Accepted
2018-06-11 11:11:35
Documents
53
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt043018form10q.htm 10-Q 1048694
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 23228
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16041
4 EXHIBIT 32 ex32.htm EX-32 4067
  Complete submission text file 0001607062-18-000187.txt   3301821

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20180430.xml EX-101.INS 379583
6 XBRL SCHEMA FILE gnbt-20180430.xsd EX-101.SCH 38467
7 XBRL CALCULATION FILE gnbt-20180430_cal.xml EX-101.CAL 28284
8 XBRL DEFINITION FILE gnbt-20180430_def.xml EX-101.DEF 157277
9 XBRL LABEL FILE gnbt-20180430_lab.xml EX-101.LAB 227749
10 XBRL PRESENTATION FILE gnbt-20180430_pre.xml EX-101.PRE 209196
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 18891279
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1